1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Microbiomes Revenue
• 1.4 Market by Type
  • 1.4.1 Global Microbiomes Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Gastrointestinal Microbiome
  • 1.4.3 Genitourinary Microbiome
  • 1.4.4 Skin Microbiome
  • 1.4.5 Respiratory Microbiome
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Microbiomes Market Share by Application: 2020 VS 2026
  • 1.5.2 Testing
  • 1.5.3 Treatment
  • 1.5.4 Diagnosis
  • 1.5.5 Technology Platform
  • 1.5.6 Probiotics
  • 1.5.7 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Microbiomes Market Perspective (2015-2026)
• 2.2 Global Microbiomes Growth Trends by Regions
  • 2.2.1 Microbiomes Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Microbiomes Historic Market Share by Regions (2015-2020)
  • 2.2.3 Microbiomes Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Microbiomes Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Microbiomes Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Microbiomes Players by Market Size
  • 3.1.1 Global Top Microbiomes Players by Revenue (2015-2020)
  • 3.1.2 Global Microbiomes Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Microbiomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Microbiomes Market Concentration Ratio
  • 3.2.1 Global Microbiomes Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Microbiomes Revenue in 2019
• 3.3 Microbiomes Key Players Head office and Area Served
• 3.4 Key Players Microbiomes Product Solution and Service
• 3.5 Date of Enter into Microbiomes Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Microbiomes Historic Market Size by Type (2015-2020)
• 4.2 Global Microbiomes Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Microbiomes Market Size by Application (2015-2020)
• 5.2 Global Microbiomes Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Microbiomes Market Size (2015-2020)
• 6.2 Microbiomes Key Players in North America (2019-2020)
• 6.3 North America Microbiomes Market Size by Type (2015-2020)
• 6.4 North America Microbiomes Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Microbiomes Market Size (2015-2020)
• 7.2 Microbiomes Key Players in Europe (2019-2020)
• 7.3 Europe Microbiomes Market Size by Type (2015-2020)
• 7.4 Europe Microbiomes Market Size by Application (2015-2020)

8 China

• 8.1 China Microbiomes Market Size (2015-2020)
• 8.2 Microbiomes Key Players in China (2019-2020)
• 8.3 China Microbiomes Market Size by Type (2015-2020)
• 8.4 China Microbiomes Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Microbiomes Market Size (2015-2020)
• 9.2 Microbiomes Key Players in Japan (2019-2020)
• 9.3 Japan Microbiomes Market Size by Type (2015-2020)
• 9.4 Japan Microbiomes Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Microbiomes Market Size (2015-2020)
• 10.2 Microbiomes Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Microbiomes Market Size by Type (2015-2020)
• 10.4 Southeast Asia Microbiomes Market Size by Application (2015-2020)

11 India

• 11.1 India Microbiomes Market Size (2015-2020)
• 11.2 Microbiomes Key Players in India (2019-2020)
• 11.3 India Microbiomes Market Size by Type (2015-2020)
• 11.4 India Microbiomes Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Microbiomes Market Size (2015-2020)
• 12.2 Microbiomes Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Microbiomes Market Size by Type (2015-2020)
• 12.4 Central & South America Microbiomes Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 4D Pharma
  • 13.1.1 4D Pharma Company Details
  • 13.1.2 4D Pharma Business Overview
  • 13.1.3 4D Pharma Microbiomes Introduction
  • 13.1.4 4D Pharma Revenue in Microbiomes Business (2015-2020))
  • 13.1.5 4D Pharma Recent Development
• 13.2 Enterome BioScience
  • 13.2.1 Enterome BioScience Company Details
  • 13.2.2 Enterome BioScience Business Overview
  • 13.2.3 Enterome BioScience Microbiomes Introduction
  • 13.2.4 Enterome BioScience Revenue in Microbiomes Business (2015-2020)
  • 13.2.5 Enterome BioScience Recent Development
• 13.3 Evelo Biosciences
  • 13.3.1 Evelo Biosciences Company Details
  • 13.3.2 Evelo Biosciences Business Overview
  • 13.3.3 Evelo Biosciences Microbiomes Introduction
  • 13.3.4 Evelo Biosciences Revenue in Microbiomes Business (2015-2020)
  • 13.3.5 Evelo Biosciences Recent Development
• 13.4 Ferring
  • 13.4.1 Ferring Company Details
  • 13.4.2 Ferring Business Overview
  • 13.4.3 Ferring Microbiomes Introduction
  • 13.4.4 Ferring Revenue in Microbiomes Business (2015-2020)
  • 13.4.5 Ferring Recent Development
• 13.5 Osel
  • 13.5.1 Osel Company Details
  • 13.5.2 Osel Business Overview
  • 13.5.3 Osel Microbiomes Introduction
  • 13.5.4 Osel Revenue in Microbiomes Business (2015-2020)
  • 13.5.5 Osel Recent Development
• 13.6 Second Genome
  • 13.6.1 Second Genome Company Details
  • 13.6.2 Second Genome Business Overview
  • 13.6.3 Second Genome Microbiomes Introduction
  • 13.6.4 Second Genome Revenue in Microbiomes Business (2015-2020)
  • 13.6.5 Second Genome Recent Development
• 13.7 Seres Therapeutics
  • 13.7.1 Seres Therapeutics Company Details
  • 13.7.2 Seres Therapeutics Business Overview
  • 13.7.3 Seres Therapeutics Microbiomes Introduction
  • 13.7.4 Seres Therapeutics Revenue in Microbiomes Business (2015-2020)
  • 13.7.5 Seres Therapeutics Recent Development
• 13.8 Synlogic
  • 13.8.1 Synlogic Company Details
  • 13.8.2 Synlogic Business Overview
  • 13.8.3 Synlogic Microbiomes Introduction
  • 13.8.4 Synlogic Revenue in Microbiomes Business (2015-2020)
  • 13.8.5 Synlogic Recent Development
• 13.9 Synthetic Biologics and Vedanta Biosciences
  • 13.9.1 Synthetic Biologics and Vedanta Biosciences Company Details
  • 13.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
  • 13.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Introduction
  • 13.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2015-2020)
  • 13.9.5 Synthetic Biologics and Vedanta Biosciences Recent Development
• 13.10 Vedanta
  • 13.10.1 Vedanta Company Details
  • 13.10.2 Vedanta Business Overview
  • 13.10.3 Vedanta Microbiomes Introduction
  • 13.10.4 Vedanta Revenue in Microbiomes Business (2015-2020)
  • 13.10.5 Vedanta Recent Development
• 13.11 Rebiotix
  • 10.11.1 Rebiotix Company Details
  • 10.11.2 Rebiotix Business Overview
  • 10.11.3 Rebiotix Microbiomes Introduction
  • 10.11.4 Rebiotix Revenue in Microbiomes Business (2015-2020)
  • 10.11.5 Rebiotix Recent Development
• 13.12 ActoGeniX
  • 10.12.1 ActoGeniX Company Details
  • 10.12.2 ActoGeniX Business Overview
  • 10.12.3 ActoGeniX Microbiomes Introduction
  • 10.12.4 ActoGeniX Revenue in Microbiomes Business (2015-2020)
  • 10.12.5 ActoGeniX Recent Development
• 13.13 Enterologics
  • 10.13.1 Enterologics Company Details
  • 10.13.2 Enterologics Business Overview
  • 10.13.3 Enterologics Microbiomes Introduction
  • 10.13.4 Enterologics Revenue in Microbiomes Business (2015-2020)
  • 10.13.5 Enterologics Recent Development
• 13.14 Metabogen
  • 10.14.1 Metabogen Company Details
  • 10.14.2 Metabogen Business Overview
  • 10.14.3 Metabogen Microbiomes Introduction
  • 10.14.4 Metabogen Revenue in Microbiomes Business (2015-2020)
  • 10.14.5 Metabogen Recent Development
• 13.15 Metabiomics
  • 10.15.1 Metabiomics Company Details
  • 10.15.2 Metabiomics Business Overview
  • 10.15.3 Metabiomics Microbiomes Introduction
  • 10.15.4 Metabiomics Revenue in Microbiomes Business (2015-2020)
  • 10.15.5 Metabiomics Recent Development
• 13.16 Ritter Pharmaceuticals
  • 10.16.1 Ritter Pharmaceuticals Company Details
  • 10.16.2 Ritter Pharmaceuticals Business Overview
  • 10.16.3 Ritter Pharmaceuticals Microbiomes Introduction
  • 10.16.4 Ritter Pharmaceuticals Revenue in Microbiomes Business (2015-2020)
  • 10.16.5 Ritter Pharmaceuticals Recent Development
• 13.17 AvidBiotics
  • 10.17.1 AvidBiotics Company Details
  • 10.17.2 AvidBiotics Business Overview
  • 10.17.3 AvidBiotics Microbiomes Introduction
  • 10.17.4 AvidBiotics Revenue in Microbiomes Business (2015-2020)
  • 10.17.5 AvidBiotics Recent Development
• 13.18 Symberix
  • 10.18.1 Symberix Company Details
  • 10.18.2 Symberix Business Overview
  • 10.18.3 Symberix Microbiomes Introduction
  • 10.18.4 Symberix Revenue in Microbiomes Business (2015-2020)
  • 10.18.5 Symberix Recent Development
• 13.19 Miomics
  • 10.19.1 Miomics Company Details
  • 10.19.2 Miomics Business Overview
  • 10.19.3 Miomics Microbiomes Introduction
  • 10.19.4 Miomics Revenue in Microbiomes Business (2015-2020)
  • 10.19.5 Miomics Recent Development
• 13.20 Symbiotix Biotherapies
  • 10.20.1 Symbiotix Biotherapies Company Details
  • 10.20.2 Symbiotix Biotherapies Business Overview
  • 10.20.3 Symbiotix Biotherapies Microbiomes Introduction
  • 10.20.4 Symbiotix Biotherapies Revenue in Microbiomes Business (2015-2020)
  • 10.20.5 Symbiotix Biotherapies Recent Development
• 13.21 MicroBiome Therapeutics LLC
  • 10.21.1 MicroBiome Therapeutics LLC Company Details
  • 10.21.2 MicroBiome Therapeutics LLC Business Overview
  • 10.21.3 MicroBiome Therapeutics LLC Microbiomes Introduction
  • 10.21.4 MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2015-2020)
  • 10.21.5 MicroBiome Therapeutics LLC Recent Development
• 13.22 SciBac Inc
  • 10.22.1 SciBac Inc Company Details
  • 10.22.2 SciBac Inc Business Overview
  • 10.22.3 SciBac Inc Microbiomes Introduction
  • 10.22.4 SciBac Inc Revenue in Microbiomes Business (2015-2020)
  • 10.22.5 SciBac Inc Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Microbiomes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Microbiomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
SciBac Inc

Market segment by Type, the product can be split into
Gastrointestinal Microbiome
Genitourinary Microbiome
Skin Microbiome
Respiratory Microbiome
Other
Market segment by Application, split into
Testing
Treatment
Diagnosis
Technology Platform
Probiotics
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America